Argus Downgrades United Therapeutics To Hold, Cites 'Challenging Outlook'

By: via Benzinga
United Therapeutics Corporation (NASDAQ: UTHR) reported its 1Q16 revenue and EPS short of consensus expectations. Argus’ Jacob ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.